Carlo Civardi

Carlo Civardi

Auto-generated profile, based on publicly available information

Carlo Civardi

Department of Neurology, ASL To4 Ivrea, P.zza Credenza, 2, 10015, Ivrea, Italy.

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1992 in Neurology
Verified
Journal Article
Closed access
PDF file
RCRoberto Cantello
Roberto Cantello
MGMaria Gianelli
Maria Gianelli
CCCarlo Civardi
Carlo Civardi
RMRoberto Mutani
Roberto Mutani
In 25 normal subjects, we studied the EMG silent period following the magnetic motor evoked potential (MEP) when the target muscle was tonically contracted (post-MEP silent period [PMSPI). In the first dorsal interosseus muscle (FDI), PMSP duration increased in linear proportion to stimulus intensity, but not to the size of the preceding MEP. The PMSP was longer in hand and forearm muscles than in upper arm muscles. In the FDI, PMSP was longer than the peripheral silent period (PSP) even when multiple peripheral stimuli were used to get M responses whose twitch force was equivalent to that of MEPs. Weak magnetic stimuli evoked silent periods preceded by no MEP in several subjects. Spinal α-motoneurons (α-MNs) were partially inhibited during the first PMSP portion, but later this effect recovered. MEPs due to weak electrical stimuli to motor cortex were only slightly inhibited during the late PMSP. Segmental inhibitory loops evoked by the muscle twitch and inhibitory projections descending to α-MNs from the cortex predominantly underlie earlier PMSP portions, but recurrent intracortical inhibition may also contribute. Later portions are predominantly due to other stimulus-related cerebral inhibitory or suppressing phenomena.

1 December 2001 in NeuroImage
Verified
Journal Article
Closed access
CCCarlo Civardi
Carlo Civardi
RCRoberto Maria Cantello
Roberto Maria Cantello
PAPeter Asselman
Peter Asselman
JRJohn Rothwell
John Rothwell

1 September 1991 in Neurology
Verified
Journal Article
Closed access
PDF file
RCR. Cantello
R. Cantello
MGM. Gianelli
M. Gianelli
DBD. Bettucci
D. Bettucci
CCC. Civardi
C. Civardi
MAM. S. De Angelis
M. S. De Angelis
RMR. Mutani
R. Mutani
We studied the EMG potentials evoked in the bilateral first dorsal interosseus muscle by electromagnetic stimulation of the corticomotoneuronal descending system in 10 Parkinson9s disease patients and in 10 age- and sex-matched normal controls. We selected patients who did not have tremor but had predominant rigidity with asymmetric body involvement. On the rigid side of the PD patients, the threshold to cortical stimulation was lower than on the contralateral side or than normal values. On average, patients had normal central conduction times, but their motor evoked potentials (MEPs) on the rigid side were larger than those of controls when the cortical stimulus was at rest or during slight tonic contraction of the target muscle. In the latter condition, a silent period shorter than that of controls followed MEPs, whereas the peripheral silent period following ulnar nerve stimulation at the wrist was prolonged. Alpha motor neuron excitability, tested by the F-wave method, was enhanced on the rigid side at rest. In rigidity, spinal motor nuclei may be more responsive than normal to descending inputs from motor cortex, or the entire corticomotoneuron system may prove hyperexcitable under given conditions.

2 February 2007 in Epilepsia
Verified
Journal Article
Open access
PDF file
RCRoberto Maria Cantello
Roberto Maria Cantello
Simone RossiSimone Rossi
Simone Rossi
CVClaudia Varrasi
Claudia Varrasi
MUMonica Ulivelli
Monica Ulivelli
CCCarlo Civardi
Carlo Civardi
PRPaolo Maria Rossini
Paolo Maria Rossini
Summary:  Purpose: To assess the effectiveness of slow repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for drug‐resistant epilepsy. Methods: Forty‐three patients with drug‐resistant epilepsy from eight Italian Centers underwent a randomized, double‐blind, sham‐controlled, crossover study on the clinical and EEG effects of slow rTMS. The stimulus frequency was 0.3 Hz. One thousand stimuli per day were given at the resting motor threshold intensity for 5 consecutive days, with a round coil at the vertex. Results:“Active” rTMS was no better than placebo for seizure reduction. However, it decreased interictal EEG epileptiform abnormalities significantly (p < 0.05) in one‐third of the patients, which supports a detectable biologic effect. No correlation linked the rTMS effects on seizure frequency to syndrome or anatomic classification, seizure type, EEG changes, or resting motor threshold (an index of motor cortex excitability). Conclusions: Although the antiepileptic action was not significant (p > 0.05), the individual EEG reactivity to “active” rTMS may be encouraging for the development of more‐powerful, noninvasive neuromodulatory strategies.

1 April 2000 in Clinical Neurophysiology
Verified
Journal Article
Closed access
CCC Civardi
C Civardi
ACA Cavalli
A Cavalli
PNP Naldi
P Naldi
CVC Varrasi
C Varrasi
RCR Cantello
R Cantello

1 December 2001 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
CCC Civardi
C Civardi
CBC Boccagni
C Boccagni
RVR Vicentini
R Vicentini
LBL Bolamperti
L Bolamperti
RTR Tarletti
R Tarletti
RCR Cantello
R Cantello
OBJECTIVES To assess the potential contribution of genetic factors to clinical phenotype in multiple sclerosis. METHODS Using a cohort of 262 pairs of coaffected siblings from 250 families with multiple sclerosis, intersibling concordance analysis was used to explore underlying genetic mechanisms in disease pathogenesis by assessing parameters of disease course, clinical presentation, age and year of onset, and measures of disability and handicap. RESULTS Adjusted intraclass correlation coefficients were not significant for either age of onset or for year of first symptom. One third of sibling pairs were concordant for presenting symptom (81/262), a result that was non-significant. However, course type was identical in 50% of the sibling pairs (κ=0.17 (95% confidence interval (95% CI) 0.08 to 0.26)) indicating a significant result. Severity of the disease at assessment, using the Kurtzke and CAMBS scales, demonstrated that whereas there was no agreement for relapse rate in the previous year within the sibship, there was significant concordance for measures of disability (κ=0.11 (95% CI 0.04 to 0.19)), progression (κ=0.09 (95% CI 0.01 to 0.18)) and handicap (κ=0.08 (95% CI 0.02 to 0.14)). CONCLUSIONS Within a sibship, the clinical presentation tends to be different. However, once established, concordance is more likely to be seen for the ultimate course, leading in the end to similar disability and handicap scores. These results are consistent with the hypothesis that genes influence both disease susceptibility and evolution in multiple sclerosis.